Vendor Consolidation Through FSP Strategy in Clinical Trials
Vendor Consolidation Through FSP Strategy in Clinical Trials Streamlining Clinical Trial Outsourcing with FSP-Based Vendor Consolidation Pharmaceutical and biotech companies often face complexity in managing dozens of external vendors for clinical trials—ranging from CROs to niche functional providers. This fragmented model leads to inconsistent quality, duplicated oversight efforts, and uncontrolled costs. A Functional Service Provider…
Read More “Vendor Consolidation Through FSP Strategy in Clinical Trials” »
